EA200001254A1 - Полипептид человеческого протеина с - Google Patents

Полипептид человеческого протеина с

Info

Publication number
EA200001254A1
EA200001254A1 EA200001254A EA200001254A EA200001254A1 EA 200001254 A1 EA200001254 A1 EA 200001254A1 EA 200001254 A EA200001254 A EA 200001254A EA 200001254 A EA200001254 A EA 200001254A EA 200001254 A1 EA200001254 A1 EA 200001254A1
Authority
EA
Eurasian Patent Office
Prior art keywords
human protein
protein polypeptide
isolated polypeptide
polypeptide
diseases
Prior art date
Application number
EA200001254A
Other languages
English (en)
Inventor
Лихуа Хуанг
Ральф Меридит Риджин
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200001254A1 publication Critical patent/EA200001254A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описан выделенный полипептид человеческого протеина С с усеченной тяжелой цепью. Этот выделенный полипептид сохраняет биологическую активность человеческого протеина С дикого типа. Этот полипептид будет полезным при лечении сосудистых окклюзивных заболеваний, состояний, характеризующихся гиперкоагуляцией, тромботических заболеваний и болезненных состояний, предрасполагающих к тромбозу.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200001254A 1998-06-01 1999-06-01 Полипептид человеческого протеина с EA200001254A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8758598P 1998-06-01 1998-06-01
PCT/US1999/011969 WO1999063070A1 (en) 1998-06-01 1999-06-01 Human protein c polypeptide

Publications (1)

Publication Number Publication Date
EA200001254A1 true EA200001254A1 (ru) 2001-06-25

Family

ID=22206075

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001254A EA200001254A1 (ru) 1998-06-01 1999-06-01 Полипептид человеческого протеина с

Country Status (25)

Country Link
US (1) US20040038288A1 (ru)
EP (1) EP1084235A4 (ru)
JP (1) JP2002517191A (ru)
KR (1) KR20010043941A (ru)
CN (1) CN1303428A (ru)
AR (1) AR020082A1 (ru)
AU (1) AU4409399A (ru)
BR (1) BR9910858A (ru)
CA (1) CA2330171A1 (ru)
CO (1) CO5070672A1 (ru)
DZ (1) DZ2803A1 (ru)
EA (1) EA200001254A1 (ru)
HR (1) HRP20000826A2 (ru)
HU (1) HUP0102014A3 (ru)
ID (1) ID27282A (ru)
IL (1) IL139595A0 (ru)
NO (1) NO20006091L (ru)
NZ (1) NZ507982A (ru)
PE (1) PE20000561A1 (ru)
PL (1) PL344349A1 (ru)
SK (1) SK17502000A3 (ru)
SV (1) SV1999000067A (ru)
TR (1) TR200003552T2 (ru)
WO (1) WO1999063070A1 (ru)
ZA (1) ZA200006647B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8821884B2 (en) * 2004-07-27 2014-09-02 The Regents Of The University Of California Compositions and methods using MD-2 mutants and chimeric proteins
CN108159399B (zh) * 2017-12-29 2020-07-24 华中科技大学同济医学院附属同济医院 一种凝血蛋白酶aPC在防治糖尿病心肌病药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
EP0506821B1 (en) * 1989-12-29 1998-02-04 Zymogenetics, Inc. Hybrid protein c
JPH05506354A (ja) * 1990-02-09 1993-09-22 ザイモジェネティクス，インコーポレイティド 端が切り取られた軽鎖を有する活性プロテインｃ
JPH0564588A (ja) * 1991-08-14 1993-03-19 Teijin Ltd 短い重鎖を有するヒトプロテインｃおよび活性化ヒトプロテインｃ

Also Published As

Publication number Publication date
CA2330171A1 (en) 1999-12-09
HUP0102014A3 (en) 2003-09-29
JP2002517191A (ja) 2002-06-18
NO20006091L (no) 2001-01-31
AU4409399A (en) 1999-12-20
PL344349A1 (en) 2001-11-05
CN1303428A (zh) 2001-07-11
EP1084235A4 (en) 2002-03-27
KR20010043941A (ko) 2001-05-25
HUP0102014A2 (hu) 2001-10-28
NO20006091D0 (no) 2000-11-30
SK17502000A3 (sk) 2001-09-11
US20040038288A1 (en) 2004-02-26
WO1999063070A1 (en) 1999-12-09
AR020082A1 (es) 2002-04-10
BR9910858A (pt) 2001-03-06
HRP20000826A2 (en) 2001-10-31
PE20000561A1 (es) 2000-07-22
TR200003552T2 (tr) 2001-05-21
NZ507982A (en) 2004-01-30
ID27282A (id) 2001-03-22
EP1084235A1 (en) 2001-03-21
ZA200006647B (en) 2001-11-15
CO5070672A1 (es) 2001-08-28
DZ2803A1 (fr) 2003-12-01
SV1999000067A (es) 2000-07-06
IL139595A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
EA199900980A1 (ru) Улучшенные способы приготовления активированного белка с
ATE57474T1 (de) Ozonentkeimung von blut und blutprodukten.
DE69027990T2 (de) Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert
DE3855970T2 (de) Verwendung von Amylin oder CGRP zur Behandlung des Diabetes mellitus
EA199700359A1 (ru) Пептиды и соединения, связывающиеся с тромбопоэтиновым рецептором
ES2074042T3 (es) Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores.
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
EA200400482A1 (ru) Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
EA200100749A1 (ru) Синтетические пептиды, обладающие поверхностной активностью, и их применение для приготовления синтетического сурфактанта
ES2037669T3 (es) Un procedimiento para preparar una sustancia que se une a la trombina.
Costa et al. Importance of metalloproteinases and macrophages in viper snake envenomation–induced local inflammation
DK37789A (da) Antikoagulerende middel samt anvendelse heraf
ES2138973T3 (es) Muteinas de il-6 exentas de cisteina.
DK0383417T3 (da) Flagmusespyt-plasminogenaktivator v-PAalfa1
EA200001254A1 (ru) Полипептид человеческого протеина с
ATE286122T1 (de) Protein c derivate
ATE55059T1 (de) Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen.
EA200401390A1 (ru) N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения
ES2070134T3 (es) Inhibidores de lisil oxidasa.
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
Gasmi et al. Purification from Vipera lebetina (desert adder) venom of a protein that depletes human complement
ATE254177T1 (de) Staphylococcus aureus v8 protease mutanten
ATE62789T1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
GB2011910A (en) Process for the Treatment of Proteinaceous Materials of Animal Origin
DE59607417D1 (de) Konjugat zur behandlung von entzündungserkrankungen